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Abstract : We evaluated clinical outcomes and prognostic factors associated with 
survival after balloon-occluded retrograde transvenous obliteration （B-RTO） of 
gastric varices in patients with portal hypertension.  Of 50 patients with gastric 
varices who underwent B-RTO, 46 （94.0%） patients in whom B-RTO was 
technically successful were reviewed retrospectively.  Gastric and esophageal 
varices after B-RTO were evaluated by contrast-enhanced computer tomogra-
phy and endoscopy, respectively.  Liver function parameters and Child-Pugh 
scores were estimated before and at 1 year after B-RTO.  The cumulative 
survival rate was calculated, and univariate and multivariate analyses were used 
to assess the prognostic factors.  No major complications occurred in any of 
the patients following B-RTO and no recurrence or bleeding of gastric varices 
was noted.  Of the 42 patients who were followed up for the progression of 
esophageal varices, 13 （31.0%） had worsened varices and of these, 6 （14.3%） 
showed bleeding.  Prothrombin activity had signicantly improved at 1 year 
after B-RTO, although there were no changes in other liver function param-
eters.  The overall cumulative survival rates at 1, 3, and 5 years after B-RTO 
were 91.6%, 70.9%, and 53.6%, respectively.  Multivariate analysis identified 
the occurrence of advanced hepatocellular carcinoma （HCC） during the obser-
vation period as a prognostic factor for survival （hazard ratio ＝ 4.1497, 95% 
CI ＝ 1.32314 - 13.0319, P ＝ 0.0148）.  B-RTO of gastric varices is an effec-
tive treatment ensuring lower recurrence and bleeding rates ; however, these 
patients require careful observation for progression of esophageal varices.  The 
management of HCC is crucial for achieving long-term survival after B-RTO.
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Introduction
　Portal hypertension causes gastroesophageal varices, which present a certain bleeding risk. 
The prevalence of gastric fundal varices （“gastric varices”） in patients with portal hyperten-
sion is approximately 30%, which is lower than that of esophageal varices 1-3）.  Although 
gastric varices also have lower reported bleeding rates ［10-36% 4-6）］ than esophageal varices, 
the clinical outcomes of bleeding from gastric varices are comparatively worse and more 
serious than those associated with esophageal varices.  Gastric variceal rupture is associated 
with a 25-55% mortality rate 3, 4, 7, 8） due to rapid and abundant blood ow in the major col-
lateral veins.
　Various endoscopic, surgical, and interventional techniques have been applied to treat 
gastric varices.  In 1984, Olson et al9） rst described a retrograde approach using a balloon 
catheter inserted into the draining vein of a gastrorenal shunt via the femoral vein, with 
ethanol as the sclerotic agent and metal coils used to induce gastric variceal thrombosis. 
In 1991, Kanagawa et al 10） introduced a balloon-occluded retrograde transvenous oblitera-
tion （B-RTO） technique in Japan ; this procedure is now widely performed because of its 
satisfactory therapeutic efcacy and low recurrence rates.  Satisfactory prognosis has been 
reported after B-RTO, with cumulative survival rates at 1, 3, and 5 years of over 90%, 
71-97%, and 54-82%, respectively 11-16）.
　The effectiveness of the treatment may be due to extreme changes in hepatic hemo-
dynamics after B-RTO.  According to portal phase splenic arteriography and computed 
tomography （CT） arterial portography via the splenic artery under conditions similar to 
those induced with the B-RTO procedure, the enhancement of the intrahepatic portal vein 
and liver parenchyma was depicted more clearly with occlusion of the major portosystemic 
shunts because of increased hepatopetal portal flow17）.  B-RTO with the occlusion of a 
major portosystemic shunt thus may increase the hepatic blood ow and possibly improve 
liver function.  However, elevation of portal pressure may be expected after obliteration of 
a major portosystemic shunt, thus leading to ascites, aggravation of esophageal varices, and 
the appearance of ectopic varices, which are potential concerns for B-RTO.  Consequently, 
B-RTO for patients with poor liver function reserve should be considered carefully ; here, 
endoscopy appears to be extremely important for identifying worsening esophageal varices.
　The development of hepatocellular carcinoma （HCC） and the Child-Pugh classification 
were reported as prognostic factors associated with survival after B-RTO 11, 15, 18）.  However, 
few studies have examined these prognostic factors in detail.  This study evaluated clinical 
outcomes after B-RTO of gastric varices and investigated the prognostic factors associated 
with survival.
Methods
　We retrospectively reviewed the medical records of all portal hypertension patients who 
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underwent B-RTO of gastric varices at Showa University Hospital from January 2000 to 
October 2010.
Patients
　We initially reviewed 50 patients with gastric varices who underwent B-RTO at our 
hospital.  In 46 （94.0%） of these patients, B-RTO was technically successful, with complete 
thrombosis of the varices being achieved, as proved by contrast-enhanced CT.  These 
patients were followed up and their cases were retrospectively reviewed.  Table 1 summa-
rizes the patient characteristics.
　The varices were related to hepatitis B virus （HBV） infection, hepatitis C virus （HCV） 
infection, habitual alcohol consumption, and other conditions.  According to the Child-
Pugh classication system, 28 patients were categorized into class A, 17 into class B, and 
1 was classied under class C.  None had mild to severe ascites or symptomatic hepatic 
coma.  The gastric varices in the fundus were subdivided into two types according to Sarin’
s classication 3, 7）: large gastric varices with esophageal varices （GOV2） and isolated gastric 
varices （IGV1）.  GOV2 and IGV1 were found in 29 （63.0%） and 17 （37.0%） patients, 
respectively.  Twenty of the total patients （43.5%） had a history of bleeding from the 
gastric varices, although because the bleeding had already stopped during the endoscopic 
observation, B-RTO was scheduled without any endoscopic therapy.  In the 26 remaining 
patients, B-RTO was performed as a prophylactic treatment.  Twenty-nine （63.0%） patients 
had esophageal varices before B-RTO ; of these, 28 had no previous episodes of bleeding, 
and thus endoscopic treatment for the esophageal varices was not performed before B-RTO. 
The endoscopic ndings of the varices were evaluated according to the general rules pro-
posed by the Japanese Research Society for Portal Hypertension 19）.  Eight （17.4%） patients 
had concomitant or past history of HCC without portal vein tumor thrombus, but the tumor 
was well controlled when B-RTO was performed.
B-RTO procedure
　The presence of a portosystemic shunt, such as a gastrorenal shunt, was confirmed in 
all patients by multidetector-row CT or magnetic resonance imaging before B-RTO, which 
Table 1.  Clinical characteristics of the 46 patients
Age, years
Gender
Cause of liver disease
Child-Pugh classication
Form of esophageal varices
Form of gastric varices
Sarin’s classication of gastric varices
Concomitant or past history of HCC （%）
Male：Female
HBV：HCV：AL：others
A：B：C
No：F0-1：F2-3
F1：F2：F3
GOV2：IGV1
63.7 ± 11.3
28：18
1：25：12：8
28：17：1
17：21：8
6：26：14
29：17
8 （17.4%）
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was performed according to the method reported by Kanagawa et al 10）.  In brief, a balloon 
catheter with a diameter of 8-20 mm （Terumo-Clinical Supply, Tokyo, Japan or Selecon MP 
catheter, Clinical Supply, Gifu, Japan） was inserted into the outlet of a gastrorenal shunt 
via the right femoral or right jugular vein.  Balloon-occluded venography （B-RTV） was 
performed with an inated balloon to conrm the demonstration of both gastric varices and 
collateral veins.  A microcatheter （Renegade, Boston Scientific Japan, Tokyo, Japan） was 
advanced close to the variceal cavity through the balloon catheter.  If the gastric varices 
did not appear because the collateral veins were dilated, then the collateral veins were 
embolized by using 50% glucose metal coils.  When the gastric varices were visualized and 
retention of the contrast medium in these varices was identied, 5% EOI was injected into 
the varices through the catheter under balloon occlusion of the balloon catheter.  The 5% 
EOI consisted of 10% ethenolamine olate （Oldamin, Takeda Pharmaceutical, Tokyo, Japan） 
diluted with the same volume of iopamidol （Iopamiron 300, Schering, Osaka, Japan）.  To 
prevent renal damage due to EOI-induced hemolysis, 4000 units of human haptoglobin 
（Yoshitomi, Osaka, Japan） was intravenously administered before the injection of 5% EOI. 
In general, the balloon catheter was positioned, 5% EOI was injected into the gastric 
variceal complex, and then the catheter was left in place overnight in all but 6 patients 
for whom the catheter was withdrawn after 30-60 min.  On the next day, the balloon was 
deated and the catheter was withdrawn after conrming thrombosis of the gastric varices 
by B-RTV.
Follow-up examination
　To evaluate the therapeutic efcacy of B-RTO of gastric varices, we performed contrast-
enhanced CT 5-7 days after the procedure.  Thereafter, contrast-enhanced CT was per-
formed every 6-12 months to examine for the recurrence of gastric varices.  Endoscopy was 
also performed to evaluate esophageal and gastric varices 4-8 weeks after B-RTO.  Risky 
varices were dened as those of moderate or large size （F2 or F3） and/or those with one 
of several marks （red wall marking, cherry red spot, or hematocystic spot）.  If the endo-
scopic ndings revealed risky varices and/or bleeding episodes of esophageal varices after 
B-RTO, endoscopic treatment such as endoscopic variceal ligation （EVL） and/or endoscopic 
injection sclerotherapy （EIS） was performed immediately.  After the first observation 
without ndings of worsening or treatment of esophageal varices, endoscopy was performed 
every 6-12 months.  Routine physical and laboratory examinations were conducted every 
2-3 months.  Depending on the patient’ s condition, the attending physician determined the 
follow-up interval.
Statistical analysis
　The results were expressed as the mean and standard deviation （SD）, median and range 
（minimum-maximum）, or percentage.  The time courses of the liver function tests after 
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B-RTO were analyzed by using a paired t-test.  The cumulative survival curve was calcu-
lated according to the Kaplan-Meier method for all the patients in whom B-RTO was suc-
cessfully performed and complete thrombosis of gastric varices was achieved.  The distribu-
tions of survival were analyzed in relation to prognostic factors such as age, gender, cause of 
liver disease, Child-Pugh classication, concomitant esophageal varices, form of gastric varices, 
location of gastric varices, and concomitant advanced HCC during the observation periods. 
Advanced HCC was dened as HCC with portal vein tumor thrombus and/or metastases to 
other organs.  Univariate analyses （log-rank tests） were used to determine the differences in 
these distributions.  The factors that appeared to have a signicant impact on survival were 
entered in a Cox proportional hazards model to test signicant effects, simultaneously adjust-
ing for multiple factors.  A P-value of less than 0.05 was considered statistically signicant 
in all the tests.  Statistical software （Ekuseru-Toukei 2008, Social Survey Research Informa-
tion Co., Ltd., Tokyo, Japan） was used for all the analyses.
Results
Outcomes of B-RTO
　B-RTO was technically successful in 46 （94.0%） of 50 patients ; the 4 remaining patients 
had several draining routes and collateral veins without gastrorenal shunts, which could 
not be occluded despite the use of 50% glucose and metal coils, resulting in insufcient 
accumulation of 5% EOI.  Of these 4 patients, 3 underwent gastric devascularization and 
splenectomy （Hassab’s operation）, while 1 underwent percutaneous transhepatic obliteration. 
In the remaining 46 patients, B-RTO was performed twice in 1 patient only.  The balloon 
catheter was placed overnight in 40 patients and for 30-60 min in 6 patients.  No major 
complications were encountered with B-RTO.
Recurrence of gastric varices
　Among the 46 patients, only 1 patient was lost to follow-up immediately after the rst 
evaluation.  The 45 remaining patients were followed up for the recurrence of gastric varices 
over the median observation period of 10 months （mean : 20.3±22.5 months ; range : 1-88 
months）.  No recurrence or bleeding from the gastric varices was noted during the observa-
tion period in any of the patients.
Progression of esophageal varices
　Of the 46 patients, 42 were followed up for the progression of esophageal varices （Table 
2）.  These varices worsened in 13 （31.0%） patients ; moreover, 6 （14.3%） of them bled 
during the median observation period of 11.5 months （mean : 19.1±19.6 months ; range : 
1-71 months）.  The patients with worsened or bleeding esophageal varices underwent EVL 
or EIS.  Of the 15 patients without esophageal varices before B-RTO, 6 showed disease 
progression, wherein 2 required emergency or elective treatment, 2 received prophylactic 
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treatment, and 2 received no treatment.  Of the 20 patients with F0-1 esophageal varices 
before B-RTO, 14 showed no changes ; however, 6 showed disease progression, wherein 3 
required emergency or elective treatment, 1 received prophylactic treatment, and 2 were 
observed without endoscopic treatment.  Among the 7 patients with F2-3 esophageal varices 
before B-RTO, 6 showed no changes, but 2 received prophylactic treatment immediately 
after B-RTO.  Of the 4 remaining patients, 3 were not treated endoscopically, since 1 under-
went liver transplantation 12 months after B-RTO, 1 died from advanced HCC, and 1 was 
transferred to another hospital.  One patient attended our hospital for further treatment. 
One patient with F2 esophageal varices suffered a bleeding episode and required emergency 
treatment.
Changes in laboratory data and Child-Pugh scores
　On average, the prothrombin activity significantly improved from 75.3±12.3% before 
B-RTO to 83.2 ± 11.7% at 1 year after B-RTO （n＝ 26 ; Table 3）.  However, the serum 
albumin level, total bilirubin level, and Child-Pugh scores did not change signicantly after 
B-RTO.
Survival rate and clinical background
　The median survival period was 13.5 months （mean : 24.8±23.5 months ; range : 1-92 
months）.  The overall cumulative survival rates at 1, 3, and 5 years after B-RTO were 
91.6%, 70.9%, and 53.6%, respectively （Fig. 1）.  In all, 13 （28.3%） patients died of the 
Table 2.  Worsening of esophageal varices after B-RTO
No. of patients
Follow-up patients
Worsening of
esophageal varices 
after B-RTO
No treatment
Endoscopic treatment
Emergent/Elective Prophylactic
No varices
（17） 15
Yes 6 2 2 2
No 9 9 0 0
F0-1 varices 
（21） 20
Yes 6 2 3 1
No 14 14 0 0
F2-3 varices 
（8） 7
Yes 1 0 1 0
No 6 4 0 2
Table 3.  Changes in laboratory data and Child-Pugh scores
Patients, no Before B-RTO 1 year after B-RTO p-value
Prothrombin time 26 75.3 ± 12.3 83.2 ± 11.7 0.0037
Albumin 29 3.3 ± 0.6 3.5 ± 0.6 0.1475
Total bilirubin 29 1.3 ± 0.8 1.3 ± 0.7 0.9594
Child-Pugh score 29 6.2 ± 1.1 6.1 ± 1.4 0.6018
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following causes : advanced HCC, 9 patients ; liver failure, 2 patients ; and other malignancies, 
2 patients.  Of these, 3 patients died due to bleeding from esophageal varices and advanced 
HCC with portal vein tumor thrombus that occurred in the observation period after B-RTO.
Prognostic factors affecting the overall survival
　The univariate analysis identied age （＞ 70 years） and occurrence of advanced HCC as 
signicant prognostic factors related to survival （Table 4）.  The multivariate analysis showed 
that the survival rate was signicantly lower in the patients with advanced HCC than in 
those without HCC （hazard ratio ＝ 4.1497, 95% CI ＝ 1.3214 - 13.0319 ; Table 5）.  The 
survival rates at 1, 3, and 5 years after B-RTO were 95.2%, 82.7%, and 65.2%, respectively, 
in the patients without advanced HCC and 76.2%, 50.8%, and 33.9%, respectively, in those 
with advanced HCC （Fig. 2）.
　The median survival period was 18.0 months （range : 1-92 months） in the patients 
without advanced HCC （n ＝ 36） and 12.5 months （range : 3-66 months） in those with 
advanced HCC （n＝ 10）.
Table 4.  Univariate analysis of prognostic factors affecting survival rate
Variable p-value
Age
Gender
Cause of liver disease
Child-Pugh classication
Concomitant esophageal varices
Form of gastric varices
Location of gastric varices
Advanced HCC
Over 70 years
Male
HBV＋HCV
B＋ C
F3
GOV2
0.0288
0.9501
0.2577
0.9794
0.3880
0.8721
0.9849
0.0064
Fig. 1.  Cumulative survival rate after B-RTO
The overall cumulative survival rates at 1, 3, and 5 years were 91.6%, 70.9%, 
and 53.6%, respectively.
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Discussion
　Since its introduction by Kanagawa et al 10）, B-RTO has become widely accepted as a 
minimally invasive, highly effective treatment for gastric varices.  In the present study, all the 
46 patients who underwent technically successful B-RTO remained free of gastric variceal 
recurrence during the observation period ; their cumulative survival rates after B-RTO were 
91.6% in the rst year, 70.9% in the third year, and 53.6% in the fth year.  Further, the 
median survival periods were 5.5 months longer in the patients without advanced HCC 
than in those with advanced HCC.  These results, which are similar to those reported previ-
ously 11-16）, suggest that successful B-RTO has a stable long-term therapeutic effect.
　Reported success rates of B-RTO of gastric varices are approximately 90%11, 12, 14, 15）; how-
ever, not all patients can be treated with this procedure.  B-RTO may be associated with 
several technical difculties leading to unfavorable results because of the complicated venous 
anatomy.  The draining route from gastric varices is variable among patients, and unexpected 
collateral veins often develop.  In general, B-RTO can be performed when there is a single 
gastrorenal shunt with minute collateral veins.  “stepwise injection” 20） and/or a “downgrad-
ing method” 21） have been attempted in cases with one gastrorenal shunt and developing 
collateral veins.  In cases of gastric varices without a gastrorenal shunt, standard B-RTO is 
Table 5.  Multivariate analysis of prognostic factors affecting survival rate
HR 95% Condence intervals p-value
Age : over 70 years 2.7916 0.8158 9.5529 0.1019
Advanced HCC 4.1497 1.3214 13.0319 0.0148
Fig. 2.   Cumulative survival rates of the patients with and without advanced 
HCC during the observation period after B-RTO 
　　　  The patients who developed advanced HCC had poorer cumulative 
survival rates than those who did not （95.2%, 82.7%, and 65.2% vs. 
76.2%, 50.8%, and 33.9% at 1, 3, and 5 years after B-RTO, respec-
tively ; P＝ 0.0054）.
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impossible to perform.  However, gastric varices without gastrorenal shunts are relatively 
infrequent ; such a condition was detected by B-RTV and arteriography in only 4 （3%） of 
130 patients in a previous study 22）.  In the present study, 4 （6.0%） of 50 patients did not 
have a detectable gastrorenal shunt ; therefore, B-RTO was not technically successful in these 
cases because the varices had several outow routes that could not be occluded by any 
means.  There are few reports of successful B-RTO through the main outow routes with 
the exception of gastrorenal shunts.  For example, if the dilated left inferior phrenic vein is 
the only draining vein from the gastric varices, complete B-RTO is possible by inserting a 
balloon catheter into this vein through the inferior vena cava23）.
　Obliterating a major portosystemic shunt via B-RTO causes hemodynamic changes.  Some 
reports indicated that B-RTO increases the portal blood ow to liver parenchyma 17）, thus 
contributing to improved liver function and reducing circulating ammonia levels18, 24-26）.  In 
our study, no changes were observed in the serum albumin level, total bilirubin level, or 
Child-Pugh scores ; however, prothrombin activity was signicantly improved at 1 year after 
B-RTO.  Our ndings thus indicated that B-RTO is valuable not only for reducing mortal-
ity due to bleeding of gastric varices, but also for improving liver function.  However, an 
increase in portal pressure cannot be avoided, and therefore, B-RTO does carry certain risks 
for the development of ascites 14, 27）, aggravation of esophageal varices 28）, and appearance of 
ectopic varices 29）.  Some patients suffer worsening of esophageal varices after B-RTO at 
a frequency of 14.3-54.4%13）, with 13 of our 42 （31.0%） patients with esophageal varices 
showing worsening during the median observation period of 11.5 months.  In a previous 
study 13）, patients without esophageal varices before B-RTO did not develop these varices, 
while those with F1 varices before B-RTO were not considered to need immediate treat-
ment because the varices did not progress rapidly.  However, patients with F2 varices are 
at a higher risk of worsening and require endoscopic treatment of their esophageal varices 
without delay after B-RTO.  The present study found no association between the worsen-
ing of esophageal varices and the form of the varices before B-RTO.  In fact, 2 （13.3%） 
of the 15 patients without esophageal varices and 3 （15.0%） of the 20 patients with F0-1 
esophageal varices underwent emergency or elective endoscopic treatment after hemorrhage, 
but no changes were observed in 6 of 8 patients with F2 esophageal varices.  Patients with 
F2-3 varices, no varices, and F0-1 varices therefore require careful observation to prevent 
the rupture of esophageal varices after B-RTO.  Incidentally, endoscopic treatment for our 
patients with F0-1 esophageal varices was not performed before B-RTO.  We consider that 
esophageal varices that progress to F2-3 after B-RTO can be managed more easily than 
those before B-RTO, because of the development or worsening of esophageal varices after 
B-RTO indicating aggravation of portal hypertension.
　Some reports have described the presence or absence of concomitant HCC and Child-
Pugh classication as prognostic factors related to survival 11, 15, 18）.  Our strategy of treatment 
for gastric varices excluded patients with Child-Pugh class C and concomitant advanced 
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HCC, because the benet of B-RTO remains unclear in Child-Pugh class C patients 30）.  We 
considered that the occurrence of advanced HCC is signicantly associated with survival after 
B-RTO because of poor prognoses in the observation period.  The development of HCC 
in chronic liver disease was the most common cause of death in our patients.  Satisfactory 
survival would depend upon careful management for preventing the advancement of HCC.
　In conclusion, B-RTO of gastric varices is an effective treatment ensuring low recurrence 
and bleeding rates ; however, these patients require careful observation for the progression 
of esophageal varices.  The present study also identied the occurrence of advanced HCC 
as a prognostic factor for survival in patients with gastric varices after B-RTO.  We believe 
that B-RTO will become the standard treatment for gastric varices with gastrorenal shunts, 
although treating worsened esophageal varices may be necessary after B-RTO.
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